Abstract

ER functions can be disturbed after excitotoxicity which leads to changes in calcium homeostasis. One approach for protecting neurons from excitotoxic damage is blocking of NMDA receptors with specific antagonists. We investigated the neuroprotective effect of DETC‐MeSO, a partial antagonist of NMDA receptors in the rat stroke model. Focal cerebral ischemia was induced by occlusion of the left middle cerebral artery for 2 hours. DETC‐MeSO (5.6 mg/kg) was administered subcutaneously for 4 days, then rats were sacrificed and infarct size in the left hemisphere was measured by TTC staining. Western Blotting on the core and the penumbra tissue of both hemispheres was done for analysis of the expression of key proteins involved in apoptosis (Bax, Bcl‐2), heat shock proteins (HSP27, HSP70), GRP78, ER stress markers (IRE1, PERK and ATF6 pathways) and p‐AKT. TTC staining showed that DETC‐MeSO can decrease the lesion volume size in the left hemisphere. Up‐regulation of Bcl‐2 to Bax ratio was seen in the core and the penumbra of treatment group. HSP27 and p‐AKT protein expression were increased in the core and the penumbra of treated group, while HSP70 and GRP78 protein expression showed no changes. Our data indicated that the administration of DETC‐MeSO can attenuate ER stress, mostly via IRE1 pathway mediated by down‐regulation of IRE1α, Ask1, JNK and GADD34 proteins and up‐regulation of Bcl‐2 protein.Grant Funding Source: Florida Department of Health

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.